Your doctor may recommend it alongside your sessions
Reid A, Miller C, Farrant JP, Polturi R, Clark D, Ray S
Consult the product monograph or a medical professional for complete prescribing information.
For people primarily concerned with gut integrity, intestinal inflammation, or ulcers, oral administration provides direct contact with the tissues that need support
Although further research is required in order to better understand its mechanisms and efficacy in practical settings, BPC 157 has the potential to be developed as a new therapy to conservatively treat or aid recovery following surgery in typically hypovascular and hypocellular soft tissues such as tendon and ligament tissue
Geriatric Use There is no information on the use of EGRIFTA WR in patients greater than 65 years of age